Rimegepant For Endometriosis Pain

Summary

The purpose of this study is to evaluate the efficacy of rimegepant 75 mg versus placebo in reducing endometriosis-associated pain (EAP) in women with moderate-to-severe pain and histologically confirmed endometriosis.

Timeline

Start

2026-09-30

Primary completion

2031-03-30

Completion

2031-09-30

Drugs

Indications